Research highlights in cancer immunotherapy from basic discovery to clinical trial
Author:
Open Access
- 12 October 2022
- journal article
- review article
- Published by Springer Nature in Holistic Integrative Oncology
- Vol. 1 (1) , 1-5
Abstract
Cancer research is one of the most active areas in the biomedical sciences. Recently, the tumor immune environment, crosstalk between tumor cells and immune cells, and immunotherapy remain the “hot” topic in the field of cancer research. This short review will highlight the recent interesting findings in cancer research associated with cancer immunology and immunotherapy from basic discovery, translational study to clinical trials.Keywords
This publication has 14 references indexed in Scilit:
- Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung CancerNew England Journal of Medicine, 2022
- Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunityCancer Cell, 2022
- Lymph node colonization induces tumor-immune tolerance to promote distant metastasisCell, 2022
- Mesothelial cell-derived antigen-presenting cancer-associated fibroblasts induce expansion of regulatory T cells in pancreatic cancerCancer Cell, 2022
- Vitamin E Enhances Cancer Immunotherapy by Reinvigorating Dendritic Cells via Targeting Checkpoint SHP1Cancer Discovery, 2022
- IFNα Potentiates Anti–PD-1 Efficacy by Remodeling Glucose Metabolism in the Hepatocellular Carcinoma MicroenvironmentCancer Discovery, 2022
- Androgen receptor activity in T cells limits checkpoint blockade efficacyNature, 2022
- Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trialCancer Cell, 2022
- Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy responseScience, 2021
- Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patientsScience, 2021